Works matching IS 00912700 AND DT 2016 AND VI 56 AND IP 2

Results: 17

Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 157, doi. 10.1002/jcph.591

By:

Lee, Lucy;
Gupta, Manish;
Sahasranaman, Srikumar

Publication type:

Article

Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 170, doi. 10.1002/jcph.616

By:

Chitayat, David;
Matsui, Doreen;
Amitai, Yona;
Kennedy, Deborah;
Vohra, Sunita;
Rieder, Michael;
Koren, Gideon

Publication type:

Article

Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 143, doi. 10.1002/jcph.562

By:

Liu, Lichuan;
Bello, Akintunde;
Dresser, Mark J.;
Heald, Donald;
Komjathy, Steven Ferenc;
O'Mara, Edward;
Rogge, Mark;
Stoch, S. Aubrey;
Robertson, Sarah M.

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 127, doi. 10.1002/jcph.700
Publication type:: Article

Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 195, doi. 10.1002/jcph.582

By:

Lal, Ritu;
Bell, Stacie;
Challenger, Rashida;
Hammock, Vakessa;
Nyberg, Mary;
Decker, Dima;
Becker, Patrice M.;
Young, David

Publication type:

Article

Population pharmacokinetic modeling and simulation for assessing renal impairment effect on the pharmacokinetics of mirogabalin.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 203, doi. 10.1002/jcph.584

By:

Yin, Ophelia Q. P.;
Merante, Domenico;
Truitt, Kenneth;
Miller, Raymond

Publication type:

Article

An integrative population pharmacokinetics approach to the characterization of the effect of hepatic impairment on clobazam pharmacokinetics.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 213, doi. 10.1002/jcph.586

By:

Tolbert, Dwain;
Bekersky, Ihor;
Chu, Hui‐May;
Ette, Ene I.

Publication type:

Article

Effect of food or proton pump inhibitor treatment on the bioavailability of dacomitinib in healthy volunteers.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 223, doi. 10.1002/jcph.588

By:

Ruiz‐Garcia, Ana;
Masters, Joanna C.;
Mendes da Costa, Laure;
LaBadie, Robert R.;
Liang, Yali;
Ni, Grace;
Ellery, Craig A.;
Boutros, Tanya;
Goldberg, Zelanna;
Bello, Carlo L.

Publication type:

Article

Effects of piragliatin, a glucokinase activator, on fasting and postprandial plasma glucose in patients with type 2 diabetes mellitus.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 231, doi. 10.1002/jcph.589

By:

Zhi, Jianguo;
Zhai, Suoping

Publication type:

Article

Measles Vaccine: Time to Stop the Madness.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 141, doi. 10.1002/jcph.654

By:

Bertino, Joseph S.

Publication type:

Article

Rapid Tolerance to Constipating Effects of Loperamide in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 248, doi. 10.1002/jcph.659

By:

Kolbow, Julia;
Weitschies, Werner;
Siegmund, Werner

Publication type:

Article

Measles vaccine: Past, present, and future.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 133, doi. 10.1002/jcph.606

By:

Zachariah, Philip;
Stockwell, Melissa S.

Publication type:

Article

Evidence-based choice of ritonavir as index CYP3A inhibitor in drug-drug interaction studies.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 152, doi. 10.1002/jcph.609

By:

Greenblatt, David J.

Publication type:

Article

Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 239, doi. 10.1002/jcph.624

By:

Kolbow, Julia;
Modess, Christiane;
Wegner, Danilo;
Oswald, Stefan;
Maritz, Martina Alice;
Rey, Hélène;
Weitschies, Werner;
Siegmund, Werner

Publication type:

Article

Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 176, doi. 10.1002/jcph.570

By:

Zhang, Xiaoping;
Imel, Erik A.;
Ruppe, Mary D.;
Weber, Thomas J.;
Klausner, Mark A.;
Ito, Takahiro;
Vergeire, Maria;
Humphrey, Jeffrey;
Glorieux, Francis H.;
Portale, Anthony A.;
Insogna, Karl;
Carpenter, Thomas O.;
Peacock, Munro

Publication type:

Article

Differential sensitivity of lipegfilgrastim and pegfilgrastim to neutrophil elastase correlates with differences in clinical pharmacokinetic profile.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 186, doi. 10.1002/jcph.578

By:

Abdolzade‐Bavil, Afsaneh;
von Kerczek, Aaron;
Cooksey, Bridget A.;
Kaufman, Thomas;
Krasney, Philip A.;
Pukac, Laurie;
Görlach, Matthias;
Lammerich, Andreas;
Scheckermann, Christian;
Allgaier, Hermann;
Shen, Wenyan David;
Liu, Patrick M.

Publication type:

Article

Extended-Release but Not Immediate-Release and Subcutaneous Methylnaltrexone Antagonizes the Loperamide-Induced Delay of the Whole-Gut Transit Time in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 2, p. 246, doi. 10.1002/jcph.647

By:

Ruan, Xiulu;
Bydalek, Katherine

Publication type:

Article